ArticleActa medica Lituanica2026
Chronic Kidney Disease in Lithuanian Children: Single Center Experience.
Article in Acta medica Lituanica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Material and Methods: A cross-sectional study of children (<18 years) with CKD stages 2-5 at Vilnius University Hospital Santaros Klinikos Pediatric Center was conducted. CKD stages were defined according to the Results: A total of 65 children were included (mean age 11.1 years; male-to-female ratio 1.7:1). CAKUT was the most common etiology of CKD (61.5%), with renal hypoplasia being the predominant variant, followed by cystic kidney diseases (13.9%), glomerulopathies (9.2%), and other or unknown causes (9.2%). The mean estimated glomerular filtration rate (eGFR) was 60.5 mL/min/1.73 m Conclusions: Pediatric CKD in Lithuania remains predominantly caused by CAKUT, with most children diagnosed with CKD stage 2. Complications occur even in early stages, and the body mass index distribution does not vary significantly across the CKD stages. Management generally aligned with KDIGO guidelines, but gaps in treating proteinuria, anemia, and growth impairment remain.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.